Vilin Bio Med Limited
Incorporated in 2005, Vilin Bio Med Limited is engaged in manufacturing pharmaceutical products.
What Vilin files
- Others37
- Insider Trade32
- Important26
- Board Meeting17
- Updates16
- JV/Acquisition2
Vilin Bio Med received a 'No Objection' from NSE for its merger with Chemgenix Laboratories. This is a crucial milestone for the amalgamation, signaling progress on a significant business development, with other approvals pending.
Vilin Bio Med teamed up with Ideal Pharma BV to expand distribution of generic and branded medicines across Europe. This move leverages Ideal Pharma's robust European distribution network, aiming to boost market presence.
Vilin Bio Med is incorporating two wholly-owned subsidiaries: Vilo Speciality Pharma to focus on Oncology products, and Axia Pharma for general & generic pharmaceuticals. Each new entity has a proposed authorized capital of 0.1 Cr, signaling strategic expansion in the pharma sector.
Vilin Bio Med confirms non-applicability of its Annual Secretarial Compliance Report for FY26. Its SME listing status provides exemption from this specific filing, simplifying regulatory obligations.
Vilin Bio Med confirmed it does not meet the criteria to be designated a Large Corporate. Consequently, specific regulatory disclosure requirements applicable to larger firms do not apply to the company.